| InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds |
Globe Newswire |
06/22 |
08:50 |
| SPARC AI Registered as AUKUS Authorised User, Opening Pathway to US and UK Defence Markets |
Globe Newswire |
06/22 |
08:45 |
| AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series |
Globe Newswire |
06/22 |
08:45 |
| Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion |
Globe Newswire |
06/22 |
08:45 |
| Ever.green Brings REI Co-op and Cutler Development Together to Support a New Solar Project in Marion County, South Carolina |
Globe Newswire |
06/22 |
08:40 |
| Independent Fire Testing Confirms Eos Z3 Battery System Exhibited No Thermal Runaway, No Sustained Fire, and No Propagation Under Abuse Testing; Company Receives ISO 14001 Certification |
Globe Newswire |
06/22 |
08:30 |
| FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing |
Globe Newswire |
06/22 |
08:30 |
| fomo Raises $75 Million Series B Led by Index Ventures To Scale Global Consumer Trading App |
Globe Newswire |
06/22 |
08:30 |
| Patriot Bank Expands into Palm Beach and the South Florida Market |
Globe Newswire |
06/22 |
08:30 |
| Kingstone Appoints Sylvie Widjaja to Lead California Business |
Globe Newswire |
06/22 |
08:30 |
| NetworkNews Audio Announces Audio Press Release (APR) Discussing AI Infrastructure Demand Creating Urgent Need for Scalable, Intelligent Automation |
Globe Newswire |
06/22 |
08:30 |
| Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis |
Globe Newswire |
06/22 |
08:30 |
| Playboy to Repurchase 16.6 Million Shares at 28% Discount to Market Value |
Globe Newswire |
06/22 |
08:30 |
| Next-Generation DNA Repair Therapies Open New Frontiers in Oncology |
Globe Newswire |
06/22 |
08:30 |
| SEALSQ’s QS7001 Post-Quantum Secure Element Aligned with New ANSSI Post Quantum Mandate |
Globe Newswire |
06/22 |
08:30 |
| Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis |
Globe Newswire |
06/22 |
08:30 |
| NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization |
Globe Newswire |
06/22 |
08:30 |
| Saratoga Investment Corp. to Report Fiscal First Quarter 2027 Financial Results and Hold Conference Call |
Globe Newswire |
06/22 |
08:30 |
| Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity |
Globe Newswire |
06/22 |
08:30 |
| CaoCao Announces Full-Scale AI Transformation, Unveils RoboX Strategy to Build a Globally Leading Physical AI Mobility Technology Platform |
Globe Newswire |
06/22 |
08:29 |
| Atlantic International Reports Record First Quarter 2026 Revenue of $249.9 Million |
Globe Newswire |
06/22 |
08:27 |
| Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery |
Globe Newswire |
06/22 |
08:22 |
| GRAL INVESTOR NOTICE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law |
Globe Newswire |
06/22 |
08:15 |
| Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts |
Globe Newswire |
06/22 |
08:05 |
| Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results |
Globe Newswire |
06/22 |
08:05 |
